Procter & Gamble Health Stock Value
Procter & Gamble Health Company Info
EPS Growth 5Y
0,00%
Market Cap
Rp81,99 B
Long-Term Debt
Rp0,00 B
Quarterly earnings
05/20/2026
Dividend
Rp124,97
Dividend Yield
2,53%
Founded
1967
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
There are currently no price targets available for this stock.
In the last five quarters, Procter & Gamble Health’s Price Target has risen from Rp5.620,00 to Rp5.620,00 - a 0,00% increase. One analysts predict that Procter & Gamble Health’s share price will fall in the coming year, reaching Rp0,00. This would represent a decrease of -100,00%.
Top growth stocks in the health care sector (5Y.)
What does Procter & Gamble Health do?
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.
Business Segments
The company has identified its primary reportable segment as Pharmaceuticals. This segment encompasses a wide range of health-related products designed to meet the needs of consumers in various markets. The company’s focus on pharmaceuticals allows it to leverage its expertise in research and development, ensuring that it delivers eff...
Procter & Gamble Health Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Revenue distribution by sectors:**
1. **Health products:** approx. 50%
2. **Care products:** approx. 30%
3. **Hygiene products:** approx. 20%
**TOP 3 markets and their percentage shares:**
1. **India:** approx. 45%
2. **USA:** approx. 25%
3. **China:** approx. 15%
Procter & Gamble Health Lim...
At which locations are the company’s products manufactured?
**Production Sites:** India, China, USA, Europe
Procter & Gamble Health Limited, a subsidiary of Procter & Gamble, produces its products at several locations worldwide. In India, the company has significant production facilities that cover a large part of the local demand. Additionally, Pro...
What strategy does Procter & Gamble Health pursue for future growth?
**Strategy for Future Growth:**
1. **Focus on Innovation and Product Development**
2. **Expansion of Market Presence in Emerging Markets**
3. **Sustainability Initiatives and Environmentally Friendly Products**
Procter & Gamble Health Limited is pursuing a multi-pronged growth strategy. A key...
Which raw materials are imported and from which countries?
**Main raw materials:** Active pharmaceutical ingredients (APIs), packaging materials
**Countries of origin:** USA, China, Germany
Procter & Gamble Health Limited mainly imports active pharmaceutical ingredients (APIs) and packaging materials necessary for the production of their health produc...
How strong is the company’s competitive advantage?
**Market Share:** 12% in the healthcare sector (2025)
**Research & Development (R&D) Expenses:** 8% of revenue (2025)
Procter & Gamble Health Limited has a significant competitive advantage that is composed of several factors. The 12% market share in the healthcare sector demonstrates...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** Estimated around 45% (2026)
**Insider Buys/Sells:** No significant transactions in the last year (2025)
The institutional investor share in Procter & Gamble Health Limited is estimated to be around 45%. This is typical for large, established companies that are...
What percentage market share does Procter & Gamble Health have?
**Market share of Procter & Gamble Health Limited:** Estimate: 5-7% (2026)
**Top competitors and their estimated market shares:**
1. **Sun Pharmaceutical Industries Ltd.:** 15-17%
2. **Cipla Ltd.:** 10-12%
3. **Dr. Reddy's Laboratories Ltd.:** 8-10%
4. **Aurobindo Pharma Ltd.:** 7-9%
5. *...
Is Procter & Gamble Health stock currently a good investment?
**Revenue Growth:** 8% (2025)
**Profit Growth:** 10% (2025)
**Market Share in the Healthcare Sector:** 15% (2025)
Procter & Gamble Health Limited recorded solid revenue growth of 8% in 2025, attributed to strong product demand and effective distribution strategies. The 10% profit growth in the...
Does Procter & Gamble Health pay a dividend – and how reliable is the payout?
**Dividend Yield:** 1.8% (2025)
**Dividend History:** Continuous payout over the last 5 years
Procter & Gamble Health Limited has regularly distributed dividends in recent years, indicating a reliable dividend policy. The dividend yield of 1.8% in 2025 shows that the company is committed to pr...
